249 related articles for article (PubMed ID: 16434387)
21. CD4+ CD56+ hematodermic neoplasm.
Cibull TL; Thomas AB; O'Malley DP; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):59-61. PubMed ID: 17284963
[TBL] [Abstract][Full Text] [Related]
22. Blastic NK-cell-like lymphoma with T-cell receptor gene rearrangement.
Liu XY; Atkins RC; Feusner JH; Rowland JM
Am J Hematol; 2004 Apr; 75(4):251-3. PubMed ID: 15054822
[TBL] [Abstract][Full Text] [Related]
23. Natural killer cell neoplasms.
Liang X; Graham DK
Cancer; 2008 Apr; 112(7):1425-36. PubMed ID: 18286525
[TBL] [Abstract][Full Text] [Related]
24. 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes.
Petrella T; Comeau MR; Maynadié M; Couillault G; De Muret A; Maliszewski CR; Dalac S; Durlach A; Galibert L
Am J Surg Pathol; 2002 Jul; 26(7):852-62. PubMed ID: 12131152
[TBL] [Abstract][Full Text] [Related]
25. CD4(+)/CD56(+) hematodermic neoplasm.
Carlesimo M; Mari E; Cortesi G; Orsini D; Narcisi A; Cox MC; Ruco L; Pulcini F; Camplone G
Eur J Dermatol; 2011; 21(2):291-2. PubMed ID: 21382786
[No Abstract] [Full Text] [Related]
26. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D
Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765
[TBL] [Abstract][Full Text] [Related]
27. Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement.
Suzuki R; Nakamura S; Suzumiya J; Ichimura K; Ichikawa M; Ogata K; Kura Y; Aikawa K; Teshima H; Sako M; Kojima H; Nishio M; Yoshino T; Sugimori H; Kawa K; Oshimi K;
Cancer; 2005 Sep; 104(5):1022-31. PubMed ID: 15999368
[TBL] [Abstract][Full Text] [Related]
28. [Hematodermic CD4/CD56 neoplasm].
Petrella T; Wechsler J; Courville P; de Muret A; Bosq J; Déchelotte P; Feuillard J; Durlach A; Vergier B
Ann Pathol; 2004 Jun; 24(3):241-55; quiz 227. PubMed ID: 15480259
[TBL] [Abstract][Full Text] [Related]
29. CD56+ lymphoma with skin involvement: clinicopathologic features and classification.
Gniadecki R; Rossen K; Ralfkier E; Thomsen K; Skovgaard GL; Jønsson V
Arch Dermatol; 2004 Apr; 140(4):427-36. PubMed ID: 15096371
[TBL] [Abstract][Full Text] [Related]
30. Childhood CD4+/CD56+ hematodermic neoplasm: case report and review of the literature.
Ruggiero A; Maurizi P; Larocca LM; Arlotta A; Riccardi R
Haematologica; 2006 Dec; 91(12 Suppl):ECR48. PubMed ID: 17194654
[TBL] [Abstract][Full Text] [Related]
31. CD4+ CD56+ hematodermic neoplasm and plasmacytoid dendritic cell tumor: case report and review of the literature.
Campbell SM; Moad JC; Sammons DL; Zirwas M
Cutis; 2012 Jun; 89(6):278-83. PubMed ID: 22838092
[TBL] [Abstract][Full Text] [Related]
32. Progress in understanding and managing natural killer-cell malignancies.
Oshimi K
Br J Haematol; 2007 Nov; 139(4):532-44. PubMed ID: 17916099
[TBL] [Abstract][Full Text] [Related]
33. Solitary cutaneous nodule of blastic plasmacytoid dendritic cell neoplasm progressing to overt leukemia cutis after chemotherapy: immunohistology and FISH analysis confirmed the diagnosis.
Kaune KM; Baumgart M; Bertsch HP; Mitteldorf C; Müller-Hermelink HK; Haase D; Ghadimi BM; Schön MP; Neumann C
Am J Dermatopathol; 2009 Oct; 31(7):695-701. PubMed ID: 19684511
[TBL] [Abstract][Full Text] [Related]
34. [Agranular CD4+ CD56+ CD123+ hematodermic neoplasm (blastic NK-cell lymphoma) revealed by cutaneous localization: 2 cases].
Machet L; De Muret A; Wiezberka E; Bernez A; Abdallah-Lotf M; Linassier C; Petrella T
Ann Dermatol Venereol; 2004 Nov; 131(11):969-73. PubMed ID: 15602384
[TBL] [Abstract][Full Text] [Related]
35. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
[TBL] [Abstract][Full Text] [Related]
36. Skin manifestations in CD4+, CD56+ malignancies.
Penven K; Macro M; Salaun V; Comoz F; Reman O; Leroy D; Troussard X; Petrella T; Dompmartin A
Eur J Dermatol; 2003; 13(2):161-5. PubMed ID: 12695132
[TBL] [Abstract][Full Text] [Related]
37. CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate.
Leitenberger JJ; Berthelot CN; Polder KD; Pro B; McLaughlin P; Jones D; Duvic M
J Am Acad Dermatol; 2008 Mar; 58(3):480-4. PubMed ID: 18280345
[TBL] [Abstract][Full Text] [Related]
38. [Retrospective analysis of 4 cases of the so-called blastic NK-cell lymphoma, with reference to the 2008 WHO classification of tumours of haematopoietic and lymphoid tissues].
Zheng YY; Chen G; Zhou XG; Jin Y; Xie JL; Zhang SH; Zhang YN
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):600-5. PubMed ID: 21092587
[TBL] [Abstract][Full Text] [Related]
39. CD4+ CD56+ blastic tumor of the skin: cytogenetic observations and further evidence of an origin from plasmocytoid dendritic cells.
Hallermann C; Middel P; Griesinger F; Gunawan B; Bertsch HP; Neumann C
Eur J Dermatol; 2004; 14(5):317-22. PubMed ID: 15358570
[TBL] [Abstract][Full Text] [Related]
40. CD8+, CD56+ (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy: clinicopathology and molecular study of five Japanese patients.
Akiyama T; Okino T; Konishi H; Wani Y; Notohara K; Tsukayama C; Tsunoda T; Tasaka T; Masaki Y; Sugihara T; Sadahira Y
Pathol Int; 2008 Oct; 58(10):626-34. PubMed ID: 18801082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
